Similar articles

• Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects.

  Underwood BR, Fox C. Underwood BR, et al. Evid Based Med. 2014 Oct;19(5):181. doi: 10.1136/ebmed-2014-110016. Epub 2014 May 13. Evid Based Med. 2014. PMID: 24824622 No abstract available.
• Treating agitation and aggression in patients with Alzheimer's disease with escitalopram.

  Žmuc Veranič L, Pregelj P, Jerin A. Žmuc Veranič L, et al. Psychogeriatrics. 2016 Nov;16(6):384-385. doi: 10.1111/psyg.12171. Epub 2015 Nov 9. Psychogeriatrics. 2016. PMID: 26551073 No abstract available.
• Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.

  Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group. Porsteinsson AP, et al. JAMA. 2014 Feb 19;311(7):682-91. doi: 10.1001/jama.2014.93. JAMA. 2014. PMID: 24549548 Free PMC article. Clinical Trial.
• When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram.

  Aga VM. Aga VM. Am J Geriatr Psychiatry. 2019 Oct;27(10):1099-1107. doi: 10.1016/j.jagp.2019.04.016. Epub 2019 May 10. Am J Geriatr Psychiatry. 2019. PMID: 31288974 Review.
• Antidepressants for agitation and psychosis in dementia.

  Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P. Seitz DP, et al. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191. doi: 10.1002/14651858.CD008191.pub2. Cochrane Database Syst Rev. 2011. PMID: 21328305 Review.